Neurogene Inc. (NGNE) Shareholders’ equity 2018–2025
Neurogene Inc. (NGNE) shareholders’ equity at each fiscal year-end, per SEC filings.
$264.9MFY2025 · since FY2018: $72.7M → $264.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $264.9M | -14.7% |
| FY2024 | $310.4M | +66.8% |
| FY2023 | $186.0M | — |
| FY2018 | $72.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice